Novo Nordisk

News

Novo enjoys strong Q1 as Trump price crackdown fails to mate...

Novo Nordisk has shaken off fears of a drug pricing crackdown from president Donald Trump, after it beat profit forecasts in Q1 results.

News

Keytruda in new lymphoma use leads latest CHMP decisions

MSD keeps pressure on BMS with EU classical Hodgkin lymphoma indication.

News

Novo Nordisk looking at M&A to revive fortunes, says CEO

Novo Nordisk’s new CEO Lars Fruergaard Joergensen says it is considering M&A to shore up performance as its key US diabetes sales come under pressure.

News

After missing out on CEO job, Novo's US head quits

The pressure on Novo Nordisk's diabetes portfolio is mounting in the US - and the situation seems even more precarious after its top exec in the region quit.

News